RU2247569C2 - Штамм lactobacillus paracasei cncm i-2116 (ncc 2461), обладающий способностью предотвращать колонизацию кишечника патогенными бактериями, вызывающими диарею, и предотвращать заражение эпителиальных клеток кишечника ротавирусами, пищевой продукт и фармацевтическая композиция для профилактики и/или лечения заболеваний, связанных с диареей - Google Patents

Штамм lactobacillus paracasei cncm i-2116 (ncc 2461), обладающий способностью предотвращать колонизацию кишечника патогенными бактериями, вызывающими диарею, и предотвращать заражение эпителиальных клеток кишечника ротавирусами, пищевой продукт и фармацевтическая композиция для профилактики и/или лечения заболеваний, связанных с диареей Download PDF

Info

Publication number
RU2247569C2
RU2247569C2 RU2001127527/13A RU2001127527A RU2247569C2 RU 2247569 C2 RU2247569 C2 RU 2247569C2 RU 2001127527/13 A RU2001127527/13 A RU 2001127527/13A RU 2001127527 A RU2001127527 A RU 2001127527A RU 2247569 C2 RU2247569 C2 RU 2247569C2
Authority
RU
Russia
Prior art keywords
cells
diarrhea
strain
ncc
milk
Prior art date
Application number
RU2001127527/13A
Other languages
English (en)
Russian (ru)
Other versions
RU2001127527A (ru
Inventor
Роберто РЕНЬЕРО (CH)
Роберто РЕНЬЕРО
Гаральд БРЮССОУ (CH)
Гаральд БРЮССОУ
Флоранс РОША (CH)
Флоранс РОША
ДЕР ВАЙД Тьерри ФОН (CH)
ДЕР ВАЙД Тьерри ФОН
Стефани БЛУМ-СПЕРИЗЕН (CH)
Стефани БЛУМ-СПЕРИЗЕН
Жан-Ришар НЕЗЕР (CH)
Жан-Ришар НЕЗЕР
Ален СЕРВЭН (FR)
Ален СЕРВЭН
Original Assignee
Сосьете Де Продюи Нестле С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сосьете Де Продюи Нестле С.А. filed Critical Сосьете Де Продюи Нестле С.А.
Publication of RU2001127527A publication Critical patent/RU2001127527A/ru
Application granted granted Critical
Publication of RU2247569C2 publication Critical patent/RU2247569C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
    • A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
    • A23G9/36—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G9/363—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Confectionery (AREA)
  • Cereal-Derived Products (AREA)
RU2001127527/13A 1999-03-11 2000-03-02 Штамм lactobacillus paracasei cncm i-2116 (ncc 2461), обладающий способностью предотвращать колонизацию кишечника патогенными бактериями, вызывающими диарею, и предотвращать заражение эпителиальных клеток кишечника ротавирусами, пищевой продукт и фармацевтическая композиция для профилактики и/или лечения заболеваний, связанных с диареей RU2247569C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99104924.8 1999-03-11
EP99104922.2 1999-03-11
EP99104922A EP1034787A1 (en) 1999-03-11 1999-03-11 Lactobacillus strains preventing diarrhea caused by pathogenic bacteria

Publications (2)

Publication Number Publication Date
RU2001127527A RU2001127527A (ru) 2003-07-20
RU2247569C2 true RU2247569C2 (ru) 2005-03-10

Family

ID=8237746

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2001127528/13A RU2243779C2 (ru) 1999-03-11 2000-03-02 Штамм молочно-кислых бактерий lactobacillus paracasei cncm i - 2116 (ncc 2461), обладающий способностью предотвращать колонизацию кишечника патогенными бактериями, вызывающими диарею, супернатант его культуры и принимаемое внутрь средство для профилактики и/или лечения нарушений, ассоциируемых с диареей
RU2001127527/13A RU2247569C2 (ru) 1999-03-11 2000-03-02 Штамм lactobacillus paracasei cncm i-2116 (ncc 2461), обладающий способностью предотвращать колонизацию кишечника патогенными бактериями, вызывающими диарею, и предотвращать заражение эпителиальных клеток кишечника ротавирусами, пищевой продукт и фармацевтическая композиция для профилактики и/или лечения заболеваний, связанных с диареей

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2001127528/13A RU2243779C2 (ru) 1999-03-11 2000-03-02 Штамм молочно-кислых бактерий lactobacillus paracasei cncm i - 2116 (ncc 2461), обладающий способностью предотвращать колонизацию кишечника патогенными бактериями, вызывающими диарею, супернатант его культуры и принимаемое внутрь средство для профилактики и/или лечения нарушений, ассоциируемых с диареей

Country Status (23)

Country Link
US (1) US6835376B1 (enExample)
EP (2) EP1034787A1 (enExample)
JP (1) JP2002537865A (enExample)
CN (1) CN1350461A (enExample)
AR (1) AR022912A1 (enExample)
AU (1) AU779414B2 (enExample)
BR (1) BR0008911A (enExample)
CA (1) CA2364435A1 (enExample)
CO (1) CO5241327A1 (enExample)
CZ (1) CZ20013264A3 (enExample)
HK (1) HK1042657A1 (enExample)
HU (1) HUP0200205A3 (enExample)
ID (1) ID30438A (enExample)
IL (2) IL145079A0 (enExample)
MY (1) MY125941A (enExample)
NO (1) NO20014299L (enExample)
NZ (1) NZ513806A (enExample)
PE (1) PE20001557A1 (enExample)
PL (1) PL355226A1 (enExample)
RO (1) RO121701B1 (enExample)
RU (2) RU2243779C2 (enExample)
WO (1) WO2000053200A1 (enExample)
ZA (2) ZA200107293B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2440123C2 (ru) * 2005-10-06 2012-01-20 Проби Аб Применение lactobacillus для лечения вирусных инфекций
RU2452243C2 (ru) * 2007-02-02 2012-06-10 МАЙ Амадеус Александер Натуральный продукт с пробиотическими микроорганизмами

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
ES2284089T3 (es) * 2000-05-25 2007-11-01 Societe Des Produits Nestle S.A. Probioticos para aplicaciones en alimentos para animales domesticos.
SE0003100D0 (sv) * 2000-09-01 2000-09-01 Probi Ab New strains
SE0003576D0 (sv) * 2000-10-04 2000-10-04 Probi Ab New strain
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
SE0103695D0 (sv) 2001-11-07 2001-11-07 Thomas Boren A novel non-antibiotic strategy against OGIP infections based on a cereal product
PT1485463E (pt) 2002-03-21 2008-12-30 Bifodan As Estirpes de lactobacillus
JP4308481B2 (ja) * 2002-06-18 2009-08-05 独立行政法人農業・食品産業技術総合研究機構 抗アレルギー剤
US20040057943A1 (en) 2002-06-28 2004-03-25 Jordi Xaus Pey Probiotic strains, a process for the selection of them, compositions thereof, and their use
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
JP2004189672A (ja) * 2002-12-11 2004-07-08 Gen Corp:Kk 抗下痢症組成物
CA2518947A1 (en) * 2003-03-13 2004-11-11 Kirin Beer Kabushiki Kaisha Antiallergic composition
US20070134220A1 (en) * 2003-04-02 2007-06-14 Axcan Pharma S.A. Lactobacillus fermentum strain and uses thereof
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
ITRM20040166A1 (it) * 2004-03-31 2004-06-30 Alberto Cresci Ceppi batterici lab con proprieta' probiotiche e composizioni che contengono gli stessi.
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
TW200637908A (en) * 2005-01-04 2006-11-01 Calpis Co Ltd Method for preparation of lactic acid bacterium having anti-allergic activity
CN101193559A (zh) 2005-04-13 2008-06-04 雀巢技术公司 具有益生菌的婴儿配方食品
US20060263311A1 (en) * 2005-05-19 2006-11-23 Scavone Timothy A Consumer noticeable improvement in wetness protection using solid antiperspirant compositions
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
AR052472A1 (es) 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
CN101420965B (zh) 2006-02-15 2013-08-07 雀巢产品技术援助有限公司 长双歧杆菌在制备预防和治疗炎症的药物中的用途
PL1993576T3 (pl) 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
CN101273737B (zh) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
EP1974735A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
ATE498325T1 (de) * 2007-07-06 2011-03-15 Nutricia Nv Verwendung von probiotika und ballaststoffen bei diarrhö
US20090110663A1 (en) * 2007-10-24 2009-04-30 Halow George M Method for treatment of bowel disorders
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2009092628A1 (en) 2008-01-24 2009-07-30 Nestec S.A. Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
WO2009112361A2 (en) 2008-03-14 2009-09-17 Nestec S.A. Synbiotic mixture
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
WO2010008491A2 (en) * 2008-06-25 2010-01-21 Ritter Natural Sciences, Llc Lactose compositions with decreased lactose content
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
DK2166083T3 (da) * 2008-12-31 2011-03-28 Syngen Biotech Co Ltd Ny Lactobacillus paracasei subsp. paracasei SG96, bakteriostatisk sammensætning indeholdende denne og anvendelse heraf
US20100196341A1 (en) * 2009-02-05 2010-08-05 Syngen Biotech Co., Ltd. Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
KR20170053733A (ko) 2009-02-24 2017-05-16 리터 파마슈티컬즈 인코오포레이티드 프리바이오틱 제제 및 사용 방법
ES2559008T3 (es) * 2009-05-11 2016-02-10 Nestec S.A. Bifidobacterium longum NCC2705 no replicante y trastornos inmunitarios
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9226521B2 (en) 2009-12-08 2016-01-05 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
RU2748839C2 (ru) 2011-06-20 2021-05-31 Х.Дж. Хайнц Компани Брэндс Ллк Композиции, способы и наборы для стимулирования мукозальной иммунной системы
ES2883552T3 (es) 2012-06-18 2021-12-09 Heinz Co Brands H J Llc Trastornos relacionados con el gluten
RU2018129984A (ru) 2013-05-10 2019-03-15 Эйч. Джей. ХАЙНЦ КОМПАНИ БРЕНДС ЛЛСи Пробиотики и способы их применения
CN107208044B (zh) 2014-12-05 2021-08-13 同生运营公司 被工程化为治疗与高氨血症相关的疾病的细菌
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
WO2016183532A1 (en) 2015-05-13 2016-11-17 Synlogic, Inc. Bacteria engineered to treat a disease or disorder
US9487764B2 (en) 2014-12-05 2016-11-08 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
US20160206666A1 (en) 2014-12-22 2016-07-21 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
BR112017018656B1 (pt) 2015-03-02 2021-11-30 Synlogic, Inc Bactéria geneticamente modificada, composição farmaceuticamente aceitável compreendendo a dita bactéria e uso da dita composição para tratar ou prevenir uma doença ou condição associada à inflamação intestinal e/ou função da barreira intestinal comprometida
EP3294760B1 (en) 2015-05-13 2021-03-24 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
EP3307879A2 (en) 2015-06-10 2018-04-18 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
WO2016210373A2 (en) 2015-06-24 2016-12-29 Synlogic, Inc. Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
US11291693B2 (en) 2015-06-25 2022-04-05 Synlogic Operating Company, Inc. Bacteria engineered to treat metabolic diseases
WO2016210378A2 (en) 2015-06-25 2016-12-29 Synlogic, Inc. Multi-layered control of gene expression in genetically engineered bacteria
AU2016303662A1 (en) 2015-07-31 2018-02-22 Synlogic Operating Company, Inc. Bacteria engineered to treat disorders involving propionate catabolism
EP3344266A1 (en) 2015-08-31 2018-07-11 Synlogic, Inc. Bacteria engineered to treat disorders in which oxalate is detrimental
US11685925B2 (en) 2015-10-30 2023-06-27 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
AU2016346646B2 (en) 2015-10-30 2022-12-01 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
WO2017075485A1 (en) 2015-10-30 2017-05-04 Synlogic, Inc. Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental
EP3377518B1 (en) 2015-11-16 2022-04-13 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
WO2017123418A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat metabolic diseases
WO2017123592A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat disorders associated with bile salts
WO2017123675A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
WO2017123610A2 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to detoxify deleterious molecules
WO2017123676A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
WO2017136795A1 (en) 2016-02-04 2017-08-10 Synlogic, Inc. Bacteria engineered to treat diseases associated with tryptophan metabolism
AU2017213646A1 (en) 2016-02-04 2018-08-23 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
WO2017139697A1 (en) 2016-02-10 2017-08-17 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
WO2017139708A1 (en) 2016-02-10 2017-08-17 Synlogic, Inc. Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
EP3454675A1 (en) * 2016-05-11 2019-03-20 Chr. Hansen A/S Lactic acid bacteria for a heat-treated food product for storage at ambient temperature
JP2020505016A (ja) 2017-01-06 2020-02-20 シンロジック オペレーティング カンパニー インコーポレイテッド 腫瘍細胞において免疫モジュレーターおよび抗がん治療剤を産生するようにプログラムされた微生物
US10941433B2 (en) 2017-06-15 2021-03-09 Iowa State University Research Foundation, Inc. Neurotransmitter transport in probiotics
AU2018290278B2 (en) 2017-06-21 2022-12-15 Synlogic Operating Company, Inc. Bacteria for the treatment of disorders
SG11201911031TA (en) 2017-07-12 2020-01-30 Synlogic Operating Co Inc Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
US20210130806A1 (en) 2017-11-03 2021-05-06 Synlogic Operating Company, Inc. Engineered bacteria expressing racemase for treating diseases associated with hyperammonemia
US11274275B2 (en) 2018-09-30 2022-03-15 Inner Mongolia Yili Industrial Group Co., Ltd. Lactobacillus paracasei ET-22 and use thereof
CN110960559B (zh) * 2018-09-30 2021-02-26 内蒙古伊利实业集团股份有限公司 用于抑制口腔病原菌的乳酸菌菌株的食品、口腔清洁以及医药组合物
EP3963046A1 (en) 2019-04-29 2022-03-09 Synlogic Operating Company, Inc. Enumeration of genetically engineered microorganisms by live cell counting techniques
EP4581941A3 (en) 2019-07-23 2025-09-10 FrieslandCampina Nederland B.V. Nutritional composition comprising milk fat and immunoglobulin
CN114364389A (zh) 2019-09-24 2022-04-15 普罗莱克塔生物科学公司 用于治疗炎性和免疫疾病的组合物和方法
CA3162642A1 (en) 2019-12-24 2021-07-01 Mark Lyte Control of histamine to promote health and control enterocolitis using probiotic compositions and/or histamine degrading
CN113355252A (zh) * 2020-03-06 2021-09-07 南京卫岗乳业有限公司 一种副干酪乳杆菌及其应用
AU2021240078A1 (en) 2020-03-20 2022-09-01 Synlogic Operating Company, Inc. Microorganisms engineered to reduce hyperphenylalaninemia
EP4195953A1 (en) 2020-08-14 2023-06-21 Prolacta Bioscience, Inc. Human milk oligosaccharide compositions for use with bacteriotherapies
CN116670269A (zh) 2020-12-02 2023-08-29 同生运营公司 工程化微生物
WO2022146718A1 (en) 2020-12-31 2022-07-07 Synlogic Operating Company, Inc. Microorganisms engineered to reduce hyperphenylalaninemia
AU2022207078A1 (en) 2021-01-12 2023-06-29 Prolacta Bioscience, Inc. Synbiotic treatment regimens
CN112625983B (zh) * 2021-03-05 2021-05-28 山东中科嘉亿生物工程有限公司 一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
CN112877260B (zh) * 2021-03-30 2022-08-09 江南大学 一株缓解泻剂结肠的副干酪乳杆菌及其应用
AU2022259522A1 (en) 2021-04-13 2023-10-19 Synlogic Operating Company, Inc. Bacteria engineered to secrete active proteins
CN115671144A (zh) * 2021-07-26 2023-02-03 锦乔生物科技有限公司 使用乳酸菌菌株的培养物来抑制肠道病原菌生长和预防和/或治疗与肠道病原菌有关的疾病
WO2023044479A1 (en) 2021-09-17 2023-03-23 Synlogic Operating Company, Inc. Methods for reducing hyperphenylalaninemia
WO2023245168A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
WO2023245171A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
CA3260270A1 (en) 2022-06-22 2023-12-28 Iowa State University Research Foundation, Inc. FIGHTING HISTAMINE TO PROMOTE HEALTH AND COMBAT ENTEROCOLITIS WITH PROBIOTIC COMPOUNDS
WO2023250478A1 (en) 2022-06-23 2023-12-28 Synlogic Operating Company, Inc. Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof
WO2024081768A1 (en) 2022-10-12 2024-04-18 Synlogic Operating Company, Inc. Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses
JP2025534764A (ja) 2022-10-17 2025-10-17 シンロジック オペレーティング カンパニー インコーポレイテッド 高フェニルアラニン血症を軽減するためのフェニルアラニンアンモニアリアーゼ、フェニルアラニントランスポーターおよびｌ－アミノ酸デアミナーゼを発現する組み換え細菌
WO2024129974A1 (en) 2022-12-14 2024-06-20 Synlogic Operating Company, Inc. Recombinant bacteria for use in the treatment of disorders in which oxalate is detrimental
WO2024130119A2 (en) 2022-12-16 2024-06-20 Prolacta Bioscience, Inc. Synbiotic compositions for short chain fatty acid production
EP4647439A1 (en) 2024-05-09 2025-11-12 Alma Mater Studiorum - Università di Bologna Non-pathogenic bacteria for delivery of ptd-fusion proteins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE153063T1 (de) * 1992-07-06 1997-05-15 Nestle Sa Milchbakterien
DE69223615T2 (de) * 1992-07-06 1998-04-09 Nestle Sa Lactobacillus Acidophilus enthaltende Antigastritis-Mittel
NZ287420A (en) * 1994-05-26 1997-12-19 Bracco Spa Lactobacillus strains with enhanced gut adhesion
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
IT1284877B1 (it) * 1996-08-09 1998-05-22 Dicofarm Spa Trattamento delle diarree acute del bambino e prevenzione della sensibilizzazione allergica verso alimenti introdotti nella fase
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
US6887465B1 (en) * 1999-03-11 2005-05-03 Nestec S.A. Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ШЕНДЕРОВ Б.А. Медицинская микробная экология и функциональное питание. Т.II. - М., 1998, Грантъ, с.91-94. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2440123C2 (ru) * 2005-10-06 2012-01-20 Проби Аб Применение lactobacillus для лечения вирусных инфекций
RU2452243C2 (ru) * 2007-02-02 2012-06-10 МАЙ Амадеус Александер Натуральный продукт с пробиотическими микроорганизмами

Also Published As

Publication number Publication date
MY125941A (en) 2006-09-29
RO121701B1 (ro) 2008-02-28
ZA200107293B (en) 2003-02-26
WO2000053200A1 (en) 2000-09-14
NZ513806A (en) 2003-08-29
PL355226A1 (en) 2004-04-05
NO20014299L (no) 2001-11-05
EP1162986A1 (en) 2001-12-19
HUP0200205A2 (hu) 2002-05-29
HK1042657A1 (zh) 2002-08-23
CN1350461A (zh) 2002-05-22
IL145079A0 (en) 2002-06-30
CO5241327A1 (es) 2003-01-31
IL145079A (en) 2006-08-01
CA2364435A1 (en) 2000-09-14
RU2243779C2 (ru) 2005-01-10
US6835376B1 (en) 2004-12-28
PE20001557A1 (es) 2001-02-01
HUP0200205A3 (en) 2002-06-28
ID30438A (id) 2001-12-06
EP1034787A1 (en) 2000-09-13
JP2002537865A (ja) 2002-11-12
AR022912A1 (es) 2002-09-04
AU3162700A (en) 2000-09-28
AU779414B2 (en) 2005-01-20
CZ20013264A3 (cs) 2002-01-16
BR0008911A (pt) 2002-01-15
NO20014299D0 (no) 2001-09-04
ZA200107290B (en) 2003-02-26

Similar Documents

Publication Publication Date Title
RU2247569C2 (ru) Штамм lactobacillus paracasei cncm i-2116 (ncc 2461), обладающий способностью предотвращать колонизацию кишечника патогенными бактериями, вызывающими диарею, и предотвращать заражение эпителиальных клеток кишечника ротавирусами, пищевой продукт и фармацевтическая композиция для профилактики и/или лечения заболеваний, связанных с диареей
US7029669B1 (en) Lactic acid bacteria strains capable of preventing diarrhoea
KR100386144B1 (ko) 헬리코박터 파일로리 （Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ）제균성 식음료 제품
US6887465B1 (en) Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
US6998119B1 (en) Feed composition containing Bifidobacterium CNCM 1-2168 capable of preventing diarrhea
MXPA01008927A (en) Lactic acid bacteria strains capable of preventing diarrhoea
MXPA01008976A (en) Lactobacillus strains preventing diarrhoea pathogenic bacteria